References

Abou-Donia, MB, Wilmarth, KR, Jensen, KF, Oehme, FW, Kurt, TL. (1996). Neurotoxicity resulting from co-exposure to pyridostigmine bromide, DEET, and permethrin. Journal of Toxicology and Environmental Health 48: 101–122.

Ahuja, EM. (1994). VA Medical market share among service-connected veterans. Statistical Brief SB 008-94-1 Washington, D.C.: National Center for Veterans Analysis and Statistics, Assistant Secretary for Policy and Planning, U.S. Department of Veterans Affairs.

Army Regulation 40-562. (November 1, 1995). By order of the Secretaries of the Air Force, Army, Navy, and Transportation.

Arrowsmith-Lowe JB, Anello C. (1994). A view from a regulatory agency. In Strom, BL (ed.) Pharmacoepidemiology 2nd Edition New York: Wiley.

Berenbaum, MC. (1981). Criteria for analyzing interactions between biologically active agents Advances in Cancer Research 35: 269–335.

Berenbaum, MC. (1985). The expected effect of a combination of agents: The general solution Journal of Theoretical Biology 114: 413–431.

Chemical Casualty Care Office, U.S. Army Medical Research Institute of Chemical Defense. (1995). Medical management of chemical casualties (2nd edition). Aberdeen, MD: Medical Research Institute of Chemical Defense.

El-Masri, HA, Thomas, RS, Mumtaz, MM, Andersen, ME, Yang, RSH (1996). A biologically based mathematical model of the effects of partial hepatectomy on cell cycle kinetics. The Toxicologist 30: 131. (Abstract.)

Farrington, CP, Nash, J, Miller, E. (1996). Case series analysis of adverse reactions to vaccines: a comparative evaluation. American Journal of Epidemiology 143: 1165-1173.

Finney, DJ. (1964). Statistical Methods in Biological Assay, 2nd edition London: Charles Griffin.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 73
Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces References Abou-Donia, MB, Wilmarth, KR, Jensen, KF, Oehme, FW, Kurt, TL. (1996). Neurotoxicity resulting from co-exposure to pyridostigmine bromide, DEET, and permethrin. Journal of Toxicology and Environmental Health 48: 101–122. Ahuja, EM. (1994). VA Medical market share among service-connected veterans. Statistical Brief SB 008-94-1 Washington, D.C.: National Center for Veterans Analysis and Statistics, Assistant Secretary for Policy and Planning, U.S. Department of Veterans Affairs. Army Regulation 40-562. (November 1, 1995). By order of the Secretaries of the Air Force, Army, Navy, and Transportation. Arrowsmith-Lowe JB, Anello C. (1994). A view from a regulatory agency. In Strom, BL (ed.) Pharmacoepidemiology 2nd Edition New York: Wiley. Berenbaum, MC. (1981). Criteria for analyzing interactions between biologically active agents Advances in Cancer Research 35: 269–335. Berenbaum, MC. (1985). The expected effect of a combination of agents: The general solution Journal of Theoretical Biology 114: 413–431. Chemical Casualty Care Office, U.S. Army Medical Research Institute of Chemical Defense. (1995). Medical management of chemical casualties (2nd edition). Aberdeen, MD: Medical Research Institute of Chemical Defense. El-Masri, HA, Thomas, RS, Mumtaz, MM, Andersen, ME, Yang, RSH (1996). A biologically based mathematical model of the effects of partial hepatectomy on cell cycle kinetics. The Toxicologist 30: 131. (Abstract.) Farrington, CP, Nash, J, Miller, E. (1996). Case series analysis of adverse reactions to vaccines: a comparative evaluation. American Journal of Epidemiology 143: 1165-1173. Finney, DJ. (1964). Statistical Methods in Biological Assay, 2nd edition London: Charles Griffin.

OCR for page 73
Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces Gennings, C, Carter, WH, Jr. (1996). Utilizing concentration-response data from individual components to detect statistically significant departures from additivity in chemical mixtures. Biometrics 51: 264–1277. Gilman, AG, et al. (1990) Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th edition. New York: Pergamon. Gizurarson, S. (1996) Optimal delivery of vaccines. Clinical pharmacokinetic considerations Clinical Pharmacokinetics 30: 1–15. Grabenstein, JD. (1990). Drug interactions involving immunologic agents. Part I. Vaccine-vaccine, vaccine-immunoglobulin, and vaccine-drug interactions Drug Intelligence and Clinical Pharmacy. The Annals of Pharmacotherapy 24: 67–81. Grabenstein, JD, Schroeder, DL, Bjornson, DC, Hartzewa, AG. (1992). Pharmacoepidemiology and military medical automation: Opportunity for excellence. Military Medicine 57: 302–307. Greenland, S. (1993). Basic problems in interaction assessment. Environmental Health Perspectives Supplements 101 (Suppl 4): 59-66. Gutthann, SP, Garcia-Rodriquez, LA. (1993). The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs Epidemiology 4: 496–501. Hansten, PD, Horn, JH. (1993) Drug Interactions. Philadelphia Lea & Febiger. Jankel, CA, Speedie, SM. (1990.) Detecting drug interactions: A review of the literature Drug Intelligence and Clinical Pharmacy 24(1): 982–989. Jankel, CA, Fitterman, LK. (1993) Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Safety 9: 51–59. Kelly, C, Rice, J. (1990) Monotone smoothing with application to dose-response curves and the assessment of synergism. Biometrics 46: 1071–1085. Kessler, DA. (1993) Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems Journal of the American Medical Association 269: 2765–2768. Kramer, P, McClain, CJ. (1981) Depression of aminopyrine metabolism by influenza vaccine. New England Journal of Medicine 305: 1262–1264. Krishnan, K, Brodeur, J. (1991) Toxicologic consequences of combined exposure to environmental pollutants. Archives of Complex Environmental Studies 3(3): 1–106. Levy, RH, Bajpai, M. (1995). Phenytoin. Interactions with other drugs: Mechanistic aspects. In Levy, RH Mattison, RH and Meldrug, BS (eds.). Anti-epileptic Drugs, 4th Edition. New York: Raven. Liang, KY, Zeger, SL. (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42(1): 121–130. Machado, SG, Robinson, GA. (1994). A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Statistics in Medicine 13: 2289-2309. Mauderly, JL. (1993) Toxicological approaches to complex mixtures. Environmental Health Perspectives Supplements 101 (Suppl 4): 155-165. McClain, CJ, Kromhout, JP, Peterson, FJ, Holtzman, JL. (1980). Potentiation of acetaminophen hepatotoxicity by alcohol. Journal of the American Medical Association 244: 251-253.

OCR for page 73
Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces Narotsky, MG, Weller, EA, Chinchilli, VM, Kavlock, RJ. (1995). Nonadditive developmental toxicity in mixtures of trichloroethylene, di(2-ethylhexyl) phthalate, and heptachlor in a 5 × 5 × 5 design. Fundamental and Applied Toxicology 27: 203–216. National Research Council. (1988). Complex Mixtures. Washington, D.C.: National Academy Press. National Research Council. (1994a). Health Effects of Permethrin-Impregnated Army Battle-Dress Uniforms. Committee on Toxicology. Washington, D.C.: National Academy Press. National Research Council. (1994b). Aggregation. In Science and Judgment in Risk Assessment. Washington, D.C.: National Academy Press. Page, WF, Braun, MM, Caporaso, NE. (1995). Ascertainment of mortality in the U.S. veteran population: World War II veteran twins. Military Medicine 160: 351–355. Page, WF, Mahan, CM, Kang, HK. (1996). Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Annals of Epidemiology 6: 102–109. Piesner, A, Arlien-Soborg, P, Herning, M. (1996). Neurological complications and Japanese encephalitis vaccination. Lancet 348: 202–203. Prentice, RL, Smythe, RT, Krewski, D, Mason, M. (1992). On the use of historical control data to estimate dose response trends in quantal bioassay. Biometrics 48: 459–478. Strom, BL (ed). (1994). Pharmacoepidemiology, 2nd edition. New York: Wiley. Tarto, DS (ed.). (1995). Drug Interaction Facts. St. Louis: Lippincott. Thomas, RS, Chubb, LS, Constan, AA, Benjamin, SA, El-Masri, HA, and Yang, RSH. (1996). A comparison of quantitative, immunohistochemical markers for cell-cycle specific changes in F344 rats. The Toxicologist 30: 130. (Abstract.) Thompson, D, Oster, G. (1996). Use of terfenadine and contraindicated drugs. Journal of the American Medical Association 275: 1339-1341. Udall JA. (1974). Warfarin-choral hydrate interaction. Pharmacological activity and clinical significance. Annals of Internal Medicine 81: 341-344. U.S. Department of Defense (1995). Immunizations and Chemoprophylaxis. Army Regulation 40-562. Bolling AFB, Washington, D.C.: U.S. Department of Defense. U.S. Environmental Protection Agency (1988). Technical Support Document on Risk Assessment of Chemical Mixtures. EPA-600/8-90/064. Washington, D.C.: U.S. Environmental Protection Agency. U.S. Office of Science and Technology Policy. (1985). Chemical carcinogens: A review of the science and its associated principles. Federal Register 50: 10372–10418.

OCR for page 73
Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces This page in the original is blank.